Jessica Page, global Impella trainer, reviews the clinical signs and symptoms of hemolysis and provides tips for reducing the risk of hemolysis in patients supported with the Impella heart pump.
To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% on Day 6 after support with Impella RP® and Impella CP®.
In the era of increasing healthcare costs, the cost-effectiveness of traditional versus emerging technologies is an ongoing consideration when evaluating long-term outcomes.
Jo Kajewski, global Impella® trainer, describes the soft buttons, waveforms, and other information displayed on the AIC placement screen when a patient is on Impella support.
Mark Anderson, MD presents his surgical perspectives on increasing survival in cardiogenic shock through escalation strategies that increase unloading.
Jo Kajewski, advanced Impella trainer, discusses how to assess the Impella access site, change dressings, and help prevent access site bleeding to improve patient outcomes.
This FAQ explains how the conclusion of Amin et al. conflicts with more robust, previously published, FDA-audited, peer-reviewed, real-world studies and RCTs.
This FAQ explains how the conclusions of Dhruva et al. conflict with Impella® best practice outcomes reported in more robust, previously published, contemporary, prospective studies.
